MedTrace Logo

Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure

NCT03189654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2020-07-30

No results posted yet for this study

Summary

There are no investigations so far whether an application of positive pressure during non-invasive ventilation might be a therapeutic option for transudative pleural effusion in patients with heart failure. In view of the pathophysiological process with pleural effusion resulting from an increase in intravascular hydrostatic pressure, non-invasive ventilation might provide an improvement.

The aim of the present study is to investigate whether an additional non-invasive ventilation therapy leads to an improved suppression of pleural effusion in heart failure patients.

Conditions

Interventions

DEVICE

Non-invasive ventilation

Non-invasive Ventilation for a Minimum of 8 h per day after pleurocentesis

Sponsors & Collaborators

  • ResMed GmbH & Co KG

    collaborator UNKNOWN

  • Heart and Diabetes Center North-Rhine Westfalia

    lead OTHER

Principal Investigators

  • Thomas Bitter, MD · Heart and Diabetes Center North Rhine-Westphalia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-12-31
Completion
2020-03-12

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189654 on ClinicalTrials.gov